| Primary |
| Product Used For Unknown Indication |
49.6% |
| Hypersensitivity |
10.4% |
| Medical Observation |
6.0% |
| Seasonal Allergy |
5.9% |
| Rhinorrhoea |
5.3% |
| Sneezing |
4.2% |
| Drug Use For Unknown Indication |
3.4% |
| Hypertension |
1.9% |
| Lacrimation Increased |
1.7% |
| Nasal Congestion |
1.5% |
| Pruritus |
1.4% |
| Rhinitis Allergic |
1.4% |
| Eye Pruritus |
1.2% |
| Nasopharyngitis |
1.2% |
| Urticaria |
1.0% |
| Throat Irritation |
0.9% |
| Cough |
0.8% |
| Diabetes Mellitus |
0.8% |
| Blood Cholesterol |
0.8% |
| Multiple Allergies |
0.7% |
|
| Drug Ineffective |
48.2% |
| Overdose |
13.3% |
| Somnolence |
5.5% |
| Accidental Overdose |
5.2% |
| Drug Effect Decreased |
5.1% |
| Off Label Use |
4.0% |
| No Therapeutic Response |
2.3% |
| Expired Drug Administered |
2.2% |
| Headache |
2.1% |
| Dizziness |
1.8% |
| Insomnia |
1.4% |
| Convulsion |
1.1% |
| Therapeutic Product Ineffective |
1.1% |
| Loss Of Consciousness |
1.1% |
| Nausea |
1.0% |
| Palpitations |
0.9% |
| Pruritus |
0.9% |
| Drug Hypersensitivity |
0.9% |
| Malaise |
0.9% |
| Rash |
0.9% |
|
| Secondary |
| Product Used For Unknown Indication |
22.3% |
| Medical Observation |
10.2% |
| Hypersensitivity |
10.0% |
| Rhinorrhoea |
8.3% |
| Sneezing |
7.7% |
| Seasonal Allergy |
6.4% |
| Hypertension |
5.4% |
| Asthma |
4.6% |
| Lacrimation Increased |
4.3% |
| Drug Use For Unknown Indication |
3.8% |
| Eye Pruritus |
3.3% |
| Nasal Congestion |
2.0% |
| Throat Irritation |
1.7% |
| Cough |
1.6% |
| Diabetes Mellitus |
1.6% |
| Blood Cholesterol |
1.4% |
| Menopause |
1.4% |
| Cholelithiasis |
1.4% |
| Back Pain |
1.3% |
| Cerebral Infarction |
1.3% |
|
| Drug Ineffective |
39.0% |
| Overdose |
14.2% |
| Somnolence |
7.3% |
| No Therapeutic Response |
6.4% |
| Off Label Use |
4.5% |
| Drug Effect Decreased |
4.3% |
| Accidental Overdose |
3.9% |
| Tubulointerstitial Nephritis |
2.5% |
| Palpitations |
2.4% |
| Dizziness |
2.0% |
| Headache |
1.6% |
| Therapeutic Response Unexpected |
1.6% |
| Throat Irritation |
1.5% |
| Anaphylactic Reaction |
1.3% |
| Pruritus |
1.3% |
| Unevaluable Event |
1.3% |
| Vomiting |
1.3% |
| Rash |
1.2% |
| Sneezing |
1.2% |
| Vision Blurred |
1.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.8% |
| Drug Use For Unknown Indication |
14.6% |
| Asthma |
6.2% |
| Hypersensitivity |
6.1% |
| Hypertension |
5.9% |
| Pain |
4.9% |
| Depression |
3.8% |
| Rheumatoid Arthritis |
3.5% |
| Gastrooesophageal Reflux Disease |
3.4% |
| Premedication |
2.8% |
| Multiple Allergies |
2.7% |
| Seasonal Allergy |
2.6% |
| Prophylaxis |
2.6% |
| Crohn's Disease |
2.5% |
| Osteoporosis |
2.4% |
| Anxiety |
2.4% |
| Contraception |
2.2% |
| Hepatitis C |
1.9% |
| Chronic Obstructive Pulmonary Disease |
1.8% |
| Insomnia |
1.7% |
|
| Vomiting |
11.6% |
| Weight Decreased |
9.1% |
| Weight Increased |
8.1% |
| Pulmonary Embolism |
6.7% |
| Pain |
6.4% |
| Nausea |
6.2% |
| Urinary Tract Infection |
5.0% |
| Rash |
4.9% |
| Drug Ineffective |
4.7% |
| Urticaria |
4.4% |
| Pneumonia |
3.9% |
| Pruritus |
3.7% |
| Headache |
3.5% |
| Myocardial Infarction |
3.4% |
| Tremor |
3.4% |
| Dyspnoea |
3.0% |
| Vision Blurred |
3.0% |
| Pyrexia |
3.0% |
| Sinusitis |
2.9% |
| Pain In Extremity |
2.9% |
|
| Interacting |
| Product Used For Unknown Indication |
72.3% |
| Drug Use For Unknown Indication |
7.9% |
| Urticaria |
5.0% |
| Onychomycosis |
4.0% |
| Seasonal Allergy |
3.0% |
| Hypersensitivity |
2.0% |
| Convulsion |
1.0% |
| Musculoskeletal Pain |
1.0% |
| Neck Pain |
1.0% |
| Pain In Extremity |
1.0% |
| Pyrexia |
1.0% |
| Type 2 Diabetes Mellitus |
1.0% |
|
| Drug Interaction |
22.2% |
| Hallucination |
11.1% |
| Loss Of Consciousness |
11.1% |
| Psychomotor Hyperactivity |
11.1% |
| Condition Aggravated |
5.6% |
| Dementia |
5.6% |
| Hepatic Enzyme Increased |
5.6% |
| Hepatitis Acute |
5.6% |
| Somnolence |
5.6% |
| Swelling |
5.6% |
| Tachycardia |
5.6% |
| Weight Increased |
5.6% |
|
